nodes	percent_of_prediction	percent_of_DWPC	metapath
Simvastatin—SLCO1A2—Spironolactone—dilated cardiomyopathy	0.226	0.297	CbGbCtD
Simvastatin—ABCC2—Spironolactone—dilated cardiomyopathy	0.188	0.246	CbGbCtD
Simvastatin—ABCC2—Furosemide—dilated cardiomyopathy	0.128	0.168	CbGbCtD
Simvastatin—CYP2C8—Spironolactone—dilated cardiomyopathy	0.0904	0.118	CbGbCtD
Simvastatin—ABCB1—Lisinopril—dilated cardiomyopathy	0.0695	0.091	CbGbCtD
Simvastatin—ABCB1—Spironolactone—dilated cardiomyopathy	0.0612	0.0801	CbGbCtD
Simvastatin—Antinuclear antibody positive—Lisinopril—dilated cardiomyopathy	0.00676	0.0385	CcSEcCtD
Simvastatin—CYP2C9—cardial valve—dilated cardiomyopathy	0.00621	0.436	CbGeAlD
Simvastatin—ITGB2—Integrin-mediated Cell Adhesion—MYPN—dilated cardiomyopathy	0.00573	0.123	CbGpPWpGaD
Simvastatin—Red blood cell sedimentation rate increased—Lisinopril—dilated cardiomyopathy	0.0057	0.0324	CcSEcCtD
Simvastatin—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00385	0.0219	CcSEcCtD
Simvastatin—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00337	0.0191	CcSEcCtD
Simvastatin—ITGB2—myocardium—dilated cardiomyopathy	0.00285	0.2	CbGeAlD
Simvastatin—Sleep disturbance—Lisinopril—dilated cardiomyopathy	0.00274	0.0156	CcSEcCtD
Simvastatin—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00246	0.014	CcSEcCtD
Simvastatin—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00246	0.014	CcSEcCtD
Simvastatin—Gastritis—Spironolactone—dilated cardiomyopathy	0.00242	0.0137	CcSEcCtD
Simvastatin—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00234	0.0133	CcSEcCtD
Simvastatin—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.00233	0.0133	CcSEcCtD
Simvastatin—Drug interaction—Furosemide—dilated cardiomyopathy	0.00221	0.0126	CcSEcCtD
Simvastatin—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00217	0.0124	CcSEcCtD
Simvastatin—ITGB2—Integrin family cell surface interactions—ITGB1—dilated cardiomyopathy	0.00217	0.0464	CbGpPWpGaD
Simvastatin—Vasculitis—Furosemide—dilated cardiomyopathy	0.0021	0.0119	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00209	0.0119	CcSEcCtD
Simvastatin—ITGB2—heart—dilated cardiomyopathy	0.00199	0.139	CbGeAlD
Simvastatin—Memory impairment—Lisinopril—dilated cardiomyopathy	0.00196	0.0111	CcSEcCtD
Simvastatin—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.00185	0.0105	CcSEcCtD
Simvastatin—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00179	0.0102	CcSEcCtD
Simvastatin—Proteinuria—Lisinopril—dilated cardiomyopathy	0.00175	0.00994	CcSEcCtD
Simvastatin—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.00175	0.00994	CcSEcCtD
Simvastatin—Protein urine present—Lisinopril—dilated cardiomyopathy	0.00172	0.00981	CcSEcCtD
Simvastatin—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00171	0.00972	CcSEcCtD
Simvastatin—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00169	0.00963	CcSEcCtD
Simvastatin—Swelling—Furosemide—dilated cardiomyopathy	0.00168	0.00958	CcSEcCtD
Simvastatin—Alopecia—Spironolactone—dilated cardiomyopathy	0.00167	0.0095	CcSEcCtD
Simvastatin—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00166	0.00945	CcSEcCtD
Simvastatin—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00166	0.00942	CcSEcCtD
Simvastatin—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00165	0.00936	CcSEcCtD
Simvastatin—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00158	0.009	CcSEcCtD
Simvastatin—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00157	0.00895	CcSEcCtD
Simvastatin—Purpura—Furosemide—dilated cardiomyopathy	0.00154	0.00877	CcSEcCtD
Simvastatin—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00153	0.00868	CcSEcCtD
Simvastatin—Malaise—Spironolactone—dilated cardiomyopathy	0.00148	0.00844	CcSEcCtD
Simvastatin—ITGB2—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—ITGB1—dilated cardiomyopathy	0.00148	0.0316	CbGpPWpGaD
Simvastatin—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00147	0.00837	CcSEcCtD
Simvastatin—ITGB2—Integrin-mediated Cell Adhesion—VCL—dilated cardiomyopathy	0.00147	0.0315	CbGpPWpGaD
Simvastatin—Discomfort—Spironolactone—dilated cardiomyopathy	0.00138	0.00787	CcSEcCtD
Simvastatin—ITGB2—Focal Adhesion—LAMA4—dilated cardiomyopathy	0.00137	0.0292	CbGpPWpGaD
Simvastatin—Confusional state—Spironolactone—dilated cardiomyopathy	0.00135	0.0077	CcSEcCtD
Simvastatin—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00134	0.00764	CcSEcCtD
Simvastatin—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00134	0.00761	CcSEcCtD
Simvastatin—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00134	0.00761	CcSEcCtD
Simvastatin—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00131	0.00748	CcSEcCtD
Simvastatin—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00131	0.00745	CcSEcCtD
Simvastatin—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00129	0.00733	CcSEcCtD
Simvastatin—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00128	0.00729	CcSEcCtD
Simvastatin—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00128	0.00726	CcSEcCtD
Simvastatin—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00127	0.00723	CcSEcCtD
Simvastatin—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00127	0.00722	CcSEcCtD
Simvastatin—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00126	0.00716	CcSEcCtD
Simvastatin—Eczema—Lisinopril—dilated cardiomyopathy	0.00124	0.00706	CcSEcCtD
Simvastatin—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00124	0.00706	CcSEcCtD
Simvastatin—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00123	0.00702	CcSEcCtD
Simvastatin—ITGB2—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—RAC1—dilated cardiomyopathy	0.00119	0.0254	CbGpPWpGaD
Simvastatin—HMGCR—PPARA activates gene expression—ANKRD1—dilated cardiomyopathy	0.00119	0.0254	CbGpPWpGaD
Simvastatin—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00118	0.00669	CcSEcCtD
Simvastatin—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00117	0.00667	CcSEcCtD
Simvastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ANKRD1—dilated cardiomyopathy	0.00116	0.0249	CbGpPWpGaD
Simvastatin—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00116	0.00659	CcSEcCtD
Simvastatin—Arthritis—Lisinopril—dilated cardiomyopathy	0.00115	0.00653	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00113	0.00646	CcSEcCtD
Simvastatin—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00111	0.00629	CcSEcCtD
Simvastatin—Urticaria—Spironolactone—dilated cardiomyopathy	0.00107	0.00607	CcSEcCtD
Simvastatin—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00106	0.00604	CcSEcCtD
Simvastatin—ITGB2—Extracellular matrix organization—LAMA4—dilated cardiomyopathy	0.00105	0.0225	CbGpPWpGaD
Simvastatin—ITGB2—Integrin cell surface interactions—ITGB1—dilated cardiomyopathy	0.00103	0.022	CbGpPWpGaD
Simvastatin—ABCC2—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00103	0.022	CbGpPWpGaD
Simvastatin—HMGCR—myocardium—dilated cardiomyopathy	0.00102	0.0713	CbGeAlD
Simvastatin—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.001	0.00571	CcSEcCtD
Simvastatin—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.001	0.00571	CcSEcCtD
Simvastatin—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000989	0.00563	CcSEcCtD
Simvastatin—Gastritis—Lisinopril—dilated cardiomyopathy	0.000986	0.00561	CcSEcCtD
Simvastatin—ITGB2—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—ITGB1—dilated cardiomyopathy	0.000982	0.021	CbGpPWpGaD
Simvastatin—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000972	0.00553	CcSEcCtD
Simvastatin—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000954	0.00543	CcSEcCtD
Simvastatin—Pruritus—Spironolactone—dilated cardiomyopathy	0.000949	0.0054	CcSEcCtD
Simvastatin—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000944	0.00537	CcSEcCtD
Simvastatin—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000926	0.00527	CcSEcCtD
Simvastatin—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000918	0.00522	CcSEcCtD
Simvastatin—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000895	0.00509	CcSEcCtD
Simvastatin—Erythema—Furosemide—dilated cardiomyopathy	0.000895	0.00509	CcSEcCtD
Simvastatin—Dizziness—Spironolactone—dilated cardiomyopathy	0.000887	0.00505	CcSEcCtD
Simvastatin—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000887	0.00505	CcSEcCtD
Simvastatin—Flatulence—Furosemide—dilated cardiomyopathy	0.000881	0.00502	CcSEcCtD
Simvastatin—ITGB2—Focal Adhesion—VCL—dilated cardiomyopathy	0.00088	0.0188	CbGpPWpGaD
Simvastatin—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000879	0.005	CcSEcCtD
Simvastatin—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000876	0.00498	CcSEcCtD
Simvastatin—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00086	0.00489	CcSEcCtD
Simvastatin—Depression—Lisinopril—dilated cardiomyopathy	0.000856	0.00487	CcSEcCtD
Simvastatin—Vomiting—Spironolactone—dilated cardiomyopathy	0.000853	0.00485	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000851	0.00485	CcSEcCtD
Simvastatin—Rash—Spironolactone—dilated cardiomyopathy	0.000846	0.00481	CcSEcCtD
Simvastatin—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000845	0.00481	CcSEcCtD
Simvastatin—Vision blurred—Furosemide—dilated cardiomyopathy	0.000843	0.0048	CcSEcCtD
Simvastatin—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000842	0.00479	CcSEcCtD
Simvastatin—Headache—Spironolactone—dilated cardiomyopathy	0.000841	0.00478	CcSEcCtD
Simvastatin—Jaundice—Lisinopril—dilated cardiomyopathy	0.000837	0.00476	CcSEcCtD
Simvastatin—Anaemia—Furosemide—dilated cardiomyopathy	0.000827	0.0047	CcSEcCtD
Simvastatin—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000806	0.00459	CcSEcCtD
Simvastatin—Vertigo—Furosemide—dilated cardiomyopathy	0.000804	0.00457	CcSEcCtD
Simvastatin—Leukopenia—Furosemide—dilated cardiomyopathy	0.000801	0.00456	CcSEcCtD
Simvastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.000801	0.0171	CbGpPWpGaD
Simvastatin—Nausea—Spironolactone—dilated cardiomyopathy	0.000797	0.00454	CcSEcCtD
Simvastatin—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000771	0.00439	CcSEcCtD
Simvastatin—ITGB2—Cell surface interactions at the vascular wall—ITGB1—dilated cardiomyopathy	0.000744	0.0159	CbGpPWpGaD
Simvastatin—ITGB2—Integrin-mediated Cell Adhesion—ITGB1—dilated cardiomyopathy	0.000738	0.0158	CbGpPWpGaD
Simvastatin—Confusional state—Furosemide—dilated cardiomyopathy	0.000736	0.00419	CcSEcCtD
Simvastatin—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00073	0.00415	CcSEcCtD
Simvastatin—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000729	0.00415	CcSEcCtD
Simvastatin—Flushing—Lisinopril—dilated cardiomyopathy	0.000716	0.00407	CcSEcCtD
Simvastatin—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000715	0.00407	CcSEcCtD
Simvastatin—HMGCR—heart—dilated cardiomyopathy	0.000709	0.0498	CbGeAlD
Simvastatin—ITGB2—Extracellular matrix organization—PSEN1—dilated cardiomyopathy	0.000706	0.0151	CbGpPWpGaD
Simvastatin—Anorexia—Furosemide—dilated cardiomyopathy	0.000696	0.00396	CcSEcCtD
Simvastatin—ITGB2—Extracellular matrix organization—DMD—dilated cardiomyopathy	0.000695	0.0149	CbGpPWpGaD
Simvastatin—Chills—Lisinopril—dilated cardiomyopathy	0.000692	0.00394	CcSEcCtD
Simvastatin—Alopecia—Lisinopril—dilated cardiomyopathy	0.000681	0.00388	CcSEcCtD
Simvastatin—HMGCR—TOR Signaling—RPS6KB1—dilated cardiomyopathy	0.000681	0.0146	CbGpPWpGaD
Simvastatin—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000675	0.00384	CcSEcCtD
Simvastatin—Erythema—Lisinopril—dilated cardiomyopathy	0.000671	0.00382	CcSEcCtD
Simvastatin—Flatulence—Lisinopril—dilated cardiomyopathy	0.000661	0.00376	CcSEcCtD
Simvastatin—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000657	0.00374	CcSEcCtD
Simvastatin—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000656	0.00373	CcSEcCtD
Simvastatin—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000645	0.00367	CcSEcCtD
Simvastatin—ITGB2—amb2 Integrin signaling—TNF—dilated cardiomyopathy	0.000639	0.0137	CbGpPWpGaD
Simvastatin—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000635	0.00361	CcSEcCtD
Simvastatin—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000633	0.0036	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00063	0.00359	CcSEcCtD
Simvastatin—Fatigue—Furosemide—dilated cardiomyopathy	0.000629	0.00358	CcSEcCtD
Simvastatin—Tremor—Lisinopril—dilated cardiomyopathy	0.000629	0.00358	CcSEcCtD
Simvastatin—Constipation—Furosemide—dilated cardiomyopathy	0.000624	0.00355	CcSEcCtD
Simvastatin—Pain—Furosemide—dilated cardiomyopathy	0.000624	0.00355	CcSEcCtD
Simvastatin—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000623	0.00354	CcSEcCtD
Simvastatin—Anaemia—Lisinopril—dilated cardiomyopathy	0.00062	0.00353	CcSEcCtD
Simvastatin—HMGCR—TOR Signaling—RAC1—dilated cardiomyopathy	0.000615	0.0132	CbGpPWpGaD
Simvastatin—Angioedema—Lisinopril—dilated cardiomyopathy	0.000613	0.00349	CcSEcCtD
Simvastatin—HMGCR—cardiac atrium—dilated cardiomyopathy	0.000606	0.0426	CbGeAlD
Simvastatin—Malaise—Lisinopril—dilated cardiomyopathy	0.000605	0.00344	CcSEcCtD
Simvastatin—Vertigo—Lisinopril—dilated cardiomyopathy	0.000603	0.00343	CcSEcCtD
Simvastatin—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000602	0.00342	CcSEcCtD
Simvastatin—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000601	0.00342	CcSEcCtD
Simvastatin—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000597	0.0034	CcSEcCtD
Simvastatin—ITGB2—Integrin-mediated Cell Adhesion—RAC1—dilated cardiomyopathy	0.000593	0.0127	CbGpPWpGaD
Simvastatin—Urticaria—Furosemide—dilated cardiomyopathy	0.00058	0.0033	CcSEcCtD
Simvastatin—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000577	0.00328	CcSEcCtD
Simvastatin—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000577	0.00328	CcSEcCtD
Simvastatin—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000571	0.00325	CcSEcCtD
Simvastatin—Chest pain—Lisinopril—dilated cardiomyopathy	0.000571	0.00325	CcSEcCtD
Simvastatin—Myalgia—Lisinopril—dilated cardiomyopathy	0.000571	0.00325	CcSEcCtD
Simvastatin—Anxiety—Lisinopril—dilated cardiomyopathy	0.000569	0.00324	CcSEcCtD
Simvastatin—Discomfort—Lisinopril—dilated cardiomyopathy	0.000565	0.00321	CcSEcCtD
Simvastatin—Confusional state—Lisinopril—dilated cardiomyopathy	0.000552	0.00314	CcSEcCtD
Simvastatin—Oedema—Lisinopril—dilated cardiomyopathy	0.000548	0.00312	CcSEcCtD
Simvastatin—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000548	0.00312	CcSEcCtD
Simvastatin—ITGB2—Hemostasis—TTN—dilated cardiomyopathy	0.000545	0.0117	CbGpPWpGaD
Simvastatin—Infection—Lisinopril—dilated cardiomyopathy	0.000544	0.0031	CcSEcCtD
Simvastatin—ITGB2—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—dilated cardiomyopathy	0.00054	0.0116	CbGpPWpGaD
Simvastatin—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000538	0.00306	CcSEcCtD
Simvastatin—ITGB2—Toll Like Receptor 4 (TLR4) Cascade—CD36—dilated cardiomyopathy	0.000537	0.0115	CbGpPWpGaD
Simvastatin—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000536	0.00305	CcSEcCtD
Simvastatin—Asthenia—Furosemide—dilated cardiomyopathy	0.000524	0.00298	CcSEcCtD
Simvastatin—Anorexia—Lisinopril—dilated cardiomyopathy	0.000522	0.00297	CcSEcCtD
Simvastatin—Pruritus—Furosemide—dilated cardiomyopathy	0.000517	0.00294	CcSEcCtD
Simvastatin—Diarrhoea—Furosemide—dilated cardiomyopathy	0.0005	0.00284	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000499	0.00284	CcSEcCtD
Simvastatin—Insomnia—Lisinopril—dilated cardiomyopathy	0.000495	0.00282	CcSEcCtD
Simvastatin—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000492	0.0028	CcSEcCtD
Simvastatin—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000488	0.00278	CcSEcCtD
Simvastatin—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000483	0.0103	CbGpPWpGaD
Simvastatin—Dizziness—Furosemide—dilated cardiomyopathy	0.000483	0.00275	CcSEcCtD
Simvastatin—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000482	0.00274	CcSEcCtD
Simvastatin—ITGB2—Toll-Like Receptors Cascades—CD36—dilated cardiomyopathy	0.000478	0.0102	CbGpPWpGaD
Simvastatin—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000476	0.00271	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000473	0.00269	CcSEcCtD
Simvastatin—ITGB2—Hemostasis—ACTN2—dilated cardiomyopathy	0.000473	0.0101	CbGpPWpGaD
Simvastatin—Fatigue—Lisinopril—dilated cardiomyopathy	0.000472	0.00269	CcSEcCtD
Simvastatin—Constipation—Lisinopril—dilated cardiomyopathy	0.000468	0.00267	CcSEcCtD
Simvastatin—Pain—Lisinopril—dilated cardiomyopathy	0.000468	0.00267	CcSEcCtD
Simvastatin—Vomiting—Furosemide—dilated cardiomyopathy	0.000464	0.00264	CcSEcCtD
Simvastatin—Rash—Furosemide—dilated cardiomyopathy	0.00046	0.00262	CcSEcCtD
Simvastatin—Dermatitis—Furosemide—dilated cardiomyopathy	0.00046	0.00262	CcSEcCtD
Simvastatin—Headache—Furosemide—dilated cardiomyopathy	0.000457	0.0026	CcSEcCtD
Simvastatin—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000451	0.00257	CcSEcCtD
Simvastatin—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000448	0.00255	CcSEcCtD
Simvastatin—ITGB2—Focal Adhesion—ITGB1—dilated cardiomyopathy	0.000442	0.00945	CbGpPWpGaD
Simvastatin—Urticaria—Lisinopril—dilated cardiomyopathy	0.000435	0.00248	CcSEcCtD
Simvastatin—Nausea—Furosemide—dilated cardiomyopathy	0.000434	0.00247	CcSEcCtD
Simvastatin—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000433	0.00246	CcSEcCtD
Simvastatin—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000433	0.00246	CcSEcCtD
Simvastatin—HMGCR—AMPK Signaling—RPS6KB1—dilated cardiomyopathy	0.000404	0.00865	CbGpPWpGaD
Simvastatin—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000404	0.0023	CcSEcCtD
Simvastatin—ITGB2—Hemostasis—VCL—dilated cardiomyopathy	0.000402	0.0086	CbGpPWpGaD
Simvastatin—ITGB2—Integrin-mediated Cell Adhesion—RAF1—dilated cardiomyopathy	0.000394	0.00842	CbGpPWpGaD
Simvastatin—Asthenia—Lisinopril—dilated cardiomyopathy	0.000393	0.00224	CcSEcCtD
Simvastatin—Pruritus—Lisinopril—dilated cardiomyopathy	0.000388	0.00221	CcSEcCtD
Simvastatin—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000375	0.00213	CcSEcCtD
Simvastatin—Dizziness—Lisinopril—dilated cardiomyopathy	0.000362	0.00206	CcSEcCtD
Simvastatin—ITGB2—Focal Adhesion—RAC1—dilated cardiomyopathy	0.000355	0.0076	CbGpPWpGaD
Simvastatin—Vomiting—Lisinopril—dilated cardiomyopathy	0.000348	0.00198	CcSEcCtD
Simvastatin—CYP2B6—heart—dilated cardiomyopathy	0.000346	0.0243	CbGeAlD
Simvastatin—Rash—Lisinopril—dilated cardiomyopathy	0.000345	0.00197	CcSEcCtD
Simvastatin—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000345	0.00196	CcSEcCtD
Simvastatin—Headache—Lisinopril—dilated cardiomyopathy	0.000343	0.00195	CcSEcCtD
Simvastatin—CYP2C9—heart—dilated cardiomyopathy	0.000343	0.0241	CbGeAlD
Simvastatin—ITGB2—Extracellular matrix organization—ITGB1—dilated cardiomyopathy	0.00034	0.00726	CbGpPWpGaD
Simvastatin—Nausea—Lisinopril—dilated cardiomyopathy	0.000325	0.00185	CcSEcCtD
Simvastatin—HMGCR—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000319	0.00682	CbGpPWpGaD
Simvastatin—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000308	0.00658	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.0003	0.00641	CbGpPWpGaD
Simvastatin—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000283	0.00605	CbGpPWpGaD
Simvastatin—HMGCR—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.000267	0.00571	CbGpPWpGaD
Simvastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.000261	0.00559	CbGpPWpGaD
Simvastatin—SLCO1A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00025	0.00534	CbGpPWpGaD
Simvastatin—HMGCR—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.00024	0.00514	CbGpPWpGaD
Simvastatin—ITGB2—Focal Adhesion—RAF1—dilated cardiomyopathy	0.000235	0.00504	CbGpPWpGaD
Simvastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.000235	0.00503	CbGpPWpGaD
Simvastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000213	0.00457	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—ITGB1—dilated cardiomyopathy	0.000202	0.00432	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	0.000195	0.00418	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000192	0.00412	CbGpPWpGaD
Simvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000187	0.00401	CbGpPWpGaD
Simvastatin—ABCB1—heart—dilated cardiomyopathy	0.000185	0.013	CbGeAlD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000181	0.00387	CbGpPWpGaD
Simvastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.00018	0.00385	CbGpPWpGaD
Simvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000178	0.00382	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—ITGB1—dilated cardiomyopathy	0.000174	0.00373	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—CD36—dilated cardiomyopathy	0.000172	0.00368	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000165	0.00352	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—RAC1—dilated cardiomyopathy	0.000162	0.00347	CbGpPWpGaD
Simvastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.000162	0.00347	CbGpPWpGaD
Simvastatin—ITGB2—Focal Adhesion—EGFR—dilated cardiomyopathy	0.000161	0.00345	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—CD36—dilated cardiomyopathy	0.000155	0.00332	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000155	0.00331	CbGpPWpGaD
Simvastatin—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000153	0.00327	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—CD36—dilated cardiomyopathy	0.000149	0.00318	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—RAC1—dilated cardiomyopathy	0.000146	0.00312	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—ANKRD1—dilated cardiomyopathy	0.000142	0.00304	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—RAC1—dilated cardiomyopathy	0.00014	0.003	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000137	0.00293	CbGpPWpGaD
Simvastatin—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000136	0.00292	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—TAZ—dilated cardiomyopathy	0.000133	0.00286	CbGpPWpGaD
Simvastatin—SLCO1A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00013	0.00279	CbGpPWpGaD
Simvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000129	0.00277	CbGpPWpGaD
Simvastatin—SLCO1A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000127	0.00271	CbGpPWpGaD
Simvastatin—SLCO1A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000127	0.00271	CbGpPWpGaD
Simvastatin—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000124	0.00266	CbGpPWpGaD
Simvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000123	0.00264	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—SDHA—dilated cardiomyopathy	0.000121	0.00258	CbGpPWpGaD
Simvastatin—ABCC2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000119	0.00254	CbGpPWpGaD
Simvastatin—SLCO1A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000118	0.00252	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—ANKRD1—dilated cardiomyopathy	0.000116	0.00248	CbGpPWpGaD
Simvastatin—ABCC2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000115	0.00247	CbGpPWpGaD
Simvastatin—ABCC2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000115	0.00247	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000115	0.00246	CbGpPWpGaD
Simvastatin—SLCO1B1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000111	0.00238	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—TAZ—dilated cardiomyopathy	0.000109	0.00233	CbGpPWpGaD
Simvastatin—SLCO1B1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000108	0.00232	CbGpPWpGaD
Simvastatin—SLCO1B1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000108	0.00232	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—RAF1—dilated cardiomyopathy	0.000108	0.0023	CbGpPWpGaD
Simvastatin—ABCC2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000107	0.0023	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—ITGB1—dilated cardiomyopathy	0.000106	0.00226	CbGpPWpGaD
Simvastatin—SLCO1B1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000101	0.00216	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—SDHA—dilated cardiomyopathy	9.84e-05	0.00211	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—ANKRD1—dilated cardiomyopathy	9.84e-05	0.00211	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—RAF1—dilated cardiomyopathy	9.68e-05	0.00207	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	9.64e-05	0.00206	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	9.45e-05	0.00202	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—RAF1—dilated cardiomyopathy	9.3e-05	0.00199	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—TAZ—dilated cardiomyopathy	9.25e-05	0.00198	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—CD36—dilated cardiomyopathy	9.03e-05	0.00193	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	8.96e-05	0.00192	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	8.89e-05	0.0019	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	8.88e-05	0.0019	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	8.64e-05	0.00185	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—ANKRD1—dilated cardiomyopathy	8.57e-05	0.00183	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—RAC1—dilated cardiomyopathy	8.51e-05	0.00182	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	8.44e-05	0.00181	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—SDHA—dilated cardiomyopathy	8.37e-05	0.00179	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—TAZ—dilated cardiomyopathy	8.06e-05	0.00172	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—ANKRD1—dilated cardiomyopathy	8e-05	0.00171	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	7.93e-05	0.0017	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	7.69e-05	0.00165	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—TAZ—dilated cardiomyopathy	7.52e-05	0.00161	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.36e-05	0.00158	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—ANKRD1—dilated cardiomyopathy	7.33e-05	0.00157	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—SDHA—dilated cardiomyopathy	7.29e-05	0.00156	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	7.23e-05	0.00155	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.17e-05	0.00153	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—TAZ—dilated cardiomyopathy	6.89e-05	0.00147	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—SDHA—dilated cardiomyopathy	6.8e-05	0.00145	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—ANKRD1—dilated cardiomyopathy	6.73e-05	0.00144	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—EGFR—dilated cardiomyopathy	6.64e-05	0.00142	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.46e-05	0.00138	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—EGFR—dilated cardiomyopathy	6.38e-05	0.00136	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—TAZ—dilated cardiomyopathy	6.32e-05	0.00135	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—SDHA—dilated cardiomyopathy	6.23e-05	0.00133	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—SDHA—dilated cardiomyopathy	5.72e-05	0.00122	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—RAF1—dilated cardiomyopathy	5.64e-05	0.00121	CbGpPWpGaD
Simvastatin—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.58e-05	0.00119	CbGpPWpGaD
Simvastatin—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.43e-05	0.00116	CbGpPWpGaD
Simvastatin—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.43e-05	0.00116	CbGpPWpGaD
Simvastatin—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.05e-05	0.00108	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	4.97e-05	0.00106	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	4.86e-05	0.00104	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	4.68e-05	0.001	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	4.57e-05	0.000978	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.44e-05	0.000951	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	4.42e-05	0.000946	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.33e-05	0.000926	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	4.27e-05	0.000912	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	4.23e-05	0.000905	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	4.21e-05	0.000901	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	4.18e-05	0.000895	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	4.13e-05	0.000884	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	3.96e-05	0.000847	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.9e-05	0.000834	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—EGFR—dilated cardiomyopathy	3.87e-05	0.000827	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.8e-05	0.000813	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	3.76e-05	0.000804	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.7e-05	0.000792	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	3.67e-05	0.000785	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	3.67e-05	0.000785	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	3.58e-05	0.000766	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	3.53e-05	0.000756	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	3.46e-05	0.00074	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	3.45e-05	0.000738	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	3.43e-05	0.000733	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.33e-05	0.000713	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—GPX1—dilated cardiomyopathy	3.28e-05	0.000702	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	3.25e-05	0.000695	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	3.22e-05	0.000689	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	3.2e-05	0.000684	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—CD36—dilated cardiomyopathy	3.19e-05	0.000683	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	3.12e-05	0.000667	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	2.94e-05	0.000629	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	2.91e-05	0.000623	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—AGT—dilated cardiomyopathy	2.88e-05	0.000615	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.77e-05	0.000593	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—GPX1—dilated cardiomyopathy	2.67e-05	0.000572	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—CD36—dilated cardiomyopathy	2.6e-05	0.000557	CbGpPWpGaD
Simvastatin—SLCO1A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.57e-05	0.00055	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—AGT—dilated cardiomyopathy	2.34e-05	0.000501	CbGpPWpGaD
Simvastatin—ABCC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.34e-05	0.000501	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—GPX1—dilated cardiomyopathy	2.27e-05	0.000486	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	2.26e-05	0.000484	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—CD36—dilated cardiomyopathy	2.21e-05	0.000474	CbGpPWpGaD
Simvastatin—SLCO1B1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.2e-05	0.00047	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.18e-05	0.000467	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.13e-05	0.000455	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	2.12e-05	0.000455	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—AGT—dilated cardiomyopathy	1.99e-05	0.000426	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—GPX1—dilated cardiomyopathy	1.98e-05	0.000423	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.95e-05	0.000417	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—CD36—dilated cardiomyopathy	1.93e-05	0.000412	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.92e-05	0.000411	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.91e-05	0.00041	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.9e-05	0.000407	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.9e-05	0.000406	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—GPX1—dilated cardiomyopathy	1.85e-05	0.000395	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.81e-05	0.000387	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—CD36—dilated cardiomyopathy	1.8e-05	0.000385	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.78e-05	0.00038	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—AGT—dilated cardiomyopathy	1.74e-05	0.000371	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.73e-05	0.00037	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.71e-05	0.000366	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—GPX1—dilated cardiomyopathy	1.69e-05	0.000362	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—CD36—dilated cardiomyopathy	1.65e-05	0.000353	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—AGT—dilated cardiomyopathy	1.62e-05	0.000346	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.56e-05	0.000333	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	1.55e-05	0.000332	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	1.51e-05	0.000324	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—AGT—dilated cardiomyopathy	1.48e-05	0.000318	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	1.36e-05	0.000291	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	1.15e-05	0.000246	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	1.12e-05	0.00024	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	1.12e-05	0.000239	CbGpPWpGaD
Simvastatin—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.1e-05	0.000236	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	1.09e-05	0.000234	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	1.01e-05	0.000216	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	9.85e-06	0.000211	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	9.73e-06	0.000208	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	9.47e-06	0.000203	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	8.68e-06	0.000186	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	8.53e-06	0.000182	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	8.47e-06	0.000181	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	8.45e-06	0.000181	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CD36—dilated cardiomyopathy	8.25e-06	0.000177	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	7.98e-06	0.000171	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	7.92e-06	0.000169	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	7.78e-06	0.000166	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	7.71e-06	0.000165	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	7.61e-06	0.000163	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—AGT—dilated cardiomyopathy	7.43e-06	0.000159	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	7e-06	0.00015	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	6.94e-06	0.000148	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	5.22e-06	0.000112	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	5.08e-06	0.000109	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	4.58e-06	9.79e-05	CbGpPWpGaD
